Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-138371 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 1, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
66,720
Total Value
$2,559,241.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 31, 2026 | Exercise/Conversion | 7,600 | $29.64 | $225,264.00 | 68,802 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 31, 2026 | Sale | 7,600 | $85.38 | $648,881.92 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 14,640 | $29.64 | $433,929.60 | 75,842 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 1, 2026 | Sale | 13,540 | $85.41 | $1,156,510.98 | 62,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 1, 2026 | Sale | 1,100 | $86.05 | $94,655.00 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 31, 2026 | Exercise/Conversion | 7,600 | $0.00 | $0.00 | 83,273 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 14,640 | $0.00 | $0.00 | 68,633 | Direct | โ | View Details |